NCT01061359View on ClinicalTrials.gov

Application Of Epirubicin Within A Neo-/Adjuvant Chemotherapy In Patients With Primary Breast Cancer

CompletedOBSERVATIONAL

Enrollment

1,981

Participants

Timeline

Start Date

January 31, 1999

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions

Breast Neoplasm

Interventions

DRUG

Epirubicin: Observational Study

Observational: Chemotherapy

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY